GURUFOCUS.COM » STOCK LIST » USA » NYSE » Johnson & Johnson (NYSE:JNJ) » Definitions » EPS without NRI
Switch to:

Johnson & Johnson EPS without NRI

: $6.87 (TTM As of Jun. 2022)
View and export this data going back to 1944. Start your Free Trial

Johnson & Johnson's earnings per share without non-recurring items for the three months ended in Jun. 2022 was $1.80. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2022 was $6.87.

During the past 12 months, Johnson & Johnson's average earnings per share (NRI) Growth Rate was 3.30% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 11.70% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 28.50% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 3.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Johnson & Johnson's EPS without NRI or its related term are showing as below:

JNJ' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -56.5   Med: 11.7   Max: 127.2
Current: 11.7

During the past 13 years, Johnson & Johnson's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 127.20% per year. The lowest was -56.50% per year. And the median was 11.70% per year.

JNJ's 3-Year EPS without NRI Growth Rate is ranked better than
53.63% of 826 companies
in the Drug Manufacturers industry
Industry Median: 9.10 vs JNJ: 11.70

Johnson & Johnson's EPS (Diluted) for the three months ended in Jun. 2022 was $1.80. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $6.87.

Johnson & Johnson's EPS (Basic) for the three months ended in Jun. 2022 was $1.83. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2022 was $6.98.


Johnson & Johnson EPS without NRI Historical Data

The historical data trend for Johnson & Johnson's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EPS without NRI
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 5.61 5.63 5.51 7.81

Johnson & Johnson Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
EPS without NRI Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.35 1.37 1.77 1.93 1.80

Competitive Comparison

For the Drug Manufacturers - General subindustry, Johnson & Johnson's EPS without NRI, along with its competitors' market caps and EPS without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Johnson & Johnson EPS without NRI Distribution

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's EPS without NRI distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's EPS without NRI falls into.



Johnson & Johnson EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock. In calculating earnings per share without non-recurring items, the dividends of preferred stocks and Non Operating Income need to subtracted from the total net income first.

EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Johnson & Johnson  (NYSE:JNJ) EPS without NRI Explanation

A Non Operating Income refers to an entry that appears on a company's financial statements that is unlikely to happen again. It represents a one-time expense involving an unpredictable event and is not part of a firm's normal, day-to-day operations.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Johnson & Johnson EPS without NRI Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Johnson & Johnson Business Description

Johnson & Johnson logo
Address
One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total sales are generated in the United States.
Executives
Adamczyk Darius director 855 S. MINT STREET CHARLOTTE NC 28202
Hait William officer: See Remarks ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Mammen Mathai officer: EVP, Pharm, R&D THERAVANCE,INC. 901 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Broadhurst Vanessa officer: EVP, Global Corp Aff. ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Swanson James D. officer: EVP, Chief Information Officer ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
West Nadja director 1915 REXFORD ROAD CHARLOTTE NC 28211
Decker Robert J officer: Controller, CAO ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Joly Hubert director C/O BEST BUY CO, INC. 7601 PENN AVENUE SOUTH RICHFIELD MN 55423
Weinberger Mark A director METLIFE, INC. 200 PARK AVENUE NEW YORK NY 10166
Hewson Marillyn A director C/O CARPENTER TECHNOLOGY CORPORATION PO BOX 14662 READING PA 19612-4662
Mongon Thibaut officer: Exec VP, WW Chair, Consumer JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Wengel Kathryn E officer: EVP, Chief GSC Officer JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Wolk Joseph J officer: Exec VP, CFO JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Mcevoy Ashley officer: EVP, WW Chair, Medical Devices JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Taubert Jennifer L officer: EVP, WW Chair, Pharmaceuticals JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933

Johnson & Johnson Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)